$1.48
1.33% yesterday
Nasdaq, Jun 27, 10:06 pm CET
ISIN
US0144421072
Symbol
ALEC
Sector
Industry

Alector, Inc. Stock price

$1.48
+0.22 17.46% 1M
-0.30 16.85% 6M
-0.41 21.69% YTD
-3.06 67.40% 1Y
-9.26 86.22% 3Y
-22.02 93.70% 5Y
-15.15 91.10% 10Y
-15.15 91.10% 20Y
Nasdaq, Closing price Fri, Jun 27 2025
-0.02 1.33%
ISIN
US0144421072
Symbol
ALEC
Sector
Industry

Key metrics

Basic
Market capitalization
$148.0m
Enterprise Value
$-197.1m
Net debt
$-345.1m
Cash
$354.6m
Shares outstanding
100.0m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
1.68 | 11.98
EV/Sales
negative | negative
EV/FCF
0.86
P/B
1.56
Financial Health
Equity Ratio
27.08%
Return on Equity
-93.89%
ROCE
-48.90%
ROIC
607.85%
Debt/Equity
0.10
Financials (TTM | estimate)
Revenue
$88.3m | $12.4m
EBITDA
$-141.0m | $-223.6m
EBIT
$-146.0m
Net Income
$-123.4m | $-192.2m
Free Cash Flow
$-230.1m
Growth (TTM | estimate)
Revenue
-8.34% | -87.71%
EBITDA
-1.04% | -60.16%
EBIT
-0.43%
Net Income
-2.35% | -61.43%
Free Cash Flow
-15.66%
Margin (TTM | estimate)
Gross
-
EBITDA
-159.65% | -1,809.39%
EBIT
-165.25%
Net
-139.74% | -1,555.34%
Free Cash Flow
-260.46%
More
EPS
$-1.26
FCF per Share
$-2.30
Short interest
8.06%
Employees
238.00
Rev per Employee
$420.00k
Show more

Is Alector, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Alector, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

15 Analysts have issued a Alector, Inc. forecast:

11x Buy
73%
2x Hold
13%
2x Sell
13%

Analyst Opinions

15 Analysts have issued a Alector, Inc. forecast:

Buy
73%
Hold
13%
Sell
13%

Financial data from Alector, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
88 88
8% 8%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 58 58
2% 2%
65%
- Research and Development Expense 174 174
6% 6%
197%
-141 -141
1% 1%
-160%
- Depreciation and Amortization 4.95 4.95
14% 14%
6%
EBIT (Operating Income) EBIT -146 -146
0% 0%
-165%
Net Profit -123 -123
2% 2%
-140%

In millions USD.

Don't miss a Thing! We will send you all news about Alector, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Alector, Inc. Stock News

Neutral
GlobeNewsWire
15 days ago
-- Neil Berkley, M.B.A., appointed Interim Chief Financial Officer, succeeding Marc Grasso, M.D.,  effective June 20, 2025 -- SOUTH SAN FRANCISCO, Calif., June 13, 2025 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a late-stage clinical biotechnology company focused on developing therapies to counteract the devastating progression of neurodegeneration, today announced that its Chief Financi...
Neutral
GlobeNewsWire
25 days ago
SOUTH SAN FRANCISCO, Calif., June 03, 2025 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a late-stage clinical biotechnology company focused on developing therapies to counteract the devastating progression of neurodegeneration, today announced that management will participate in a fireside chat at the Goldman Sachs 46th Annual Global Healthcare Conference on Tuesday, June 10, 2024, at 8:40...
Neutral
GlobeNewsWire
about 2 months ago
Topline data from pivotal INFRONT-3 Phase 3 clinical trial of latozinemab in FTD-GRN on track for Q4 2025 Completed enrollment in PROGRESS-AD Phase 2 clinical trial of AL101 in early Alzheimer's disease Continuing to pursue Alector Brain Carrier programs, including the company's anti-amyloid beta antibody and its GCase enzyme replacement therapy Extending runway into the second half of 2027, wi...
More Alector, Inc. News

Company Profile

Alector, Inc. operates as a clinical-stage biopharmaceutical company. It develops therapeutics for the treatment of neurodegenerative diseases including frontotemporal dementia (FTD), Alzheimer's disease, and Parkinson's disease. The company was founded by Asa Abeliovich, Errik B. Anderson, Tillman U. Gerngross, and Arnon Rosenthal in May 2013 and is headquartered in South San Francisco, CA.

Head office United States
CEO Arnon Rosenthal
Employees 238
Founded 2013
Website alector.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today